GlassScriptPhysician profile
Asif M Talukder
NPI 1952716979
$42,146.13
in general payments reported to CMS, 2019-2025
24 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.58 · 2021: $902 · 2022: $8,546 · 2023: $1,433 · 2024: $11K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $25K · Travel and Lodging: $4,638 · Long Term Medical Supply Or Device Loan: $1,970 · Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,750.00 |
| Travel and Lodging | $4,638.16 |
| Long Term Medical Supply Or Device Loan | $1,969.74 |
| Food and Beverage | $1,323.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $37,945.34 | 2022-2025 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $1,969.74 | 2024 | Integra |
| Thd America, INC. | $622.40 | 2021 | |
| Medtronic, INC. | $249.70 | 2021-2025 | Interstim |
| Baxter Healthcare | $174.74 | 2021-2024 | Seprafilm |
| Kerecis Limited | $166.55 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $134.07 | 2021-2025 | Exparel |
| Ethicon US, LLC | $130.02 | 2021-2023 | Enseal, Surgicel Nu-Knit, Echelon; Endopath |
| Braintree Laboratories, INC. | $108.13 | 2023-2025 | Suflave, Sutab |
| Heron Therapeutics, INC. | $92.86 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.85 | 2021-2024 | Gattex |
| Davol INC. | $80.43 | 2024 | Arista Ah Flexitip |
| Dilon Technologies, INC. | $63.00 | 2024-2025 | Hemoblast Bellows |
| Merck Sharp & Dohme LLC | $56.04 | 2023-2024 | Dificid |
| Innovation Technologies INC | $45.60 | 2024-2025 | Irrisept |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $33.97 | 2025 | Renasys Touch |
| Stryker Corporation | $32.21 | 2022 | |
| Conmed Corporation | $31.25 | 2022 | |
| Solventum Corporation | $29.77 | 2024 | Prevena, V.A.C. Veraflo |
| Tela Bio, INC. | $24.91 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Exact Sciences Corporation | $22.78 | 2025 | Cologuard Collection Kit |
| Covidien LP | $16.58 | 2020 | |
| Myriad Genetic Laboratories, INC. | $16.55 | 2022 | |
| Axonics, INC. | $14.64 | 2023 | Bulkamid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asif Talukder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.